Filing Flows › Cardlytics (CDLX) › Q3 2026 › vs Q3 2025
Cardlytics (CDLX) Q3 2026 vs Q3 2025 (year over year)
Cardlytics's revenue fell $14.1M (-30%) from $47.0M in Q3 2025 to $32.9M in Q3 2026. The biggest changes: Served based pricing −$8.1M (-44%); Engagement based pricing −$5.9M (-21%); Other Revenue(1) −$135K (-11%).
Cardlytics, Q3 2026: revenue $32.9M (-30% year over year), operating margin -16.5%, net loss $8.9M, operating cash flow −$5.9M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Engagement based pricing | $21.7M | $27.6M | −$5.9M | -21% |
| Served based pricing | $10.1M | $18.1M | −$8.1M | -44% |
| Other Revenue(1) | $1.1M | $1.3M | −$135K | -11% |
| Revenue | $32.9M | $47.0M | −$14.1M | -30% |
| Net loss | $8.9M | $72.7M | −$63.7M | -88% |
| Costs & expenses | $41.8M | $120M | −$77.8M | -65% |
| Operating costs | $38.3M | $113M | −$75.1M | -66% |
| Interest & other, net | $3.5M | $6.2M | −$2.7M | -43% |
| Research & development | $3.7M | $7.5M | −$3.8M | -50% |
| Sales & marketing | $6.7M | $6.5M | $133K | +2% |
| General & admin | $7.1M | $10.2M | −$3.2M | -31% |
| Other operating costs | $20.8M | $89.1M | −$68.3M | -77% |
| Operating cash sources | $11.7M | $11.1M | $572K | +5% |
| Depreciation & amortization | $4.2M | $6.5M | −$2.3M | -35% |
| Share-based compensation | $1.6M | $6.4M | −$4.8M | -75% |
| Cash used in operations | $5.9M | −$1.8M | $7.7M | — |
| Net loss absorbed | $8.9M | $72.7M | −$63.7M | -88% |
| Working capital & other | $2.8M | −$61.5M | $64.3M | — |
Questions
How much did Cardlytics's revenue grow year over year in Q3 2026?
Cardlytics's revenue fell $14.1M (-30%) from $47.0M in Q3 2025 to $32.9M in Q3 2026.
What drove Cardlytics's revenue change in Q3 2026?
Served based pricing −$8.1M (-44%); Engagement based pricing −$5.9M (-21%); Other Revenue(1) −$135K (-11%).